Aquestive Therapeutics

AQSTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$621.283 M

$4.95 +3.56%

Close of 22 Sept 2026

Revenue

$44.5M

#2768 by revenue

Earnings

-$83.8M

Loss-making

Shares outstanding

125,511,648

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#192CytomX TherapeuticsCTMX$640.6M
#193Phathom PharmaceuticalsPHAT$627.8M
#194Aquestive TherapeuticsAQST$621.3M
#195OculisOCS$621.0M
#196Crescent BiopharmaCBIO$610.6M

What if Aquestive Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$240,885.77

Per share 48,664× higher

Bitcoin $1.74T

$13,876.44

Per share 2,803× higher

Nvidia $5.52T

$43,946.26

Per share 8,878× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Aquestive Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.